1. Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. J American Med Assoc. 2020;323(8):709-10. [ DOI:10.1001/jama.2020.1097] [ PMID] 2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. [ DOI:10.1056/NEJMoa2001017] [ PMID] [ ] 3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. [ DOI:10.1016/S0140-6736(20)30183-5] [ PMID] 4. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-43. [ DOI:10.1001/jamainternmed.2020.0994] [ PMID] [ ] 5. Liu Y, Sun W, Guo Y, Chen L, Zhang L, Zhao S, et al. Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study. Platelets. 2020;31(4):490-6. [ DOI:10.1080/09537104.2020.1754383] [ PMID] [ ] 6. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. [ DOI:10.1056/NEJMoa2002032] [ PMID] [ ] 7. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. [ DOI:10.1016/S0140-6736(20)30566-3] [ PMID] 8. Yang M, Ng MH, Li CK. Thrombocytopenia in patients with severe acute respiratory syndrome. Hematology. 2005;10(2):101-5. [ DOI:10.1080/10245330400026170] [ PMID] 9. Brogly N, Devos P, Boussekey N, Georges H, Chiche A, Leroy O. Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia. J Infect. 2007;55(2):136-40. [ DOI:10.1016/j.jinf.2007.01.011] [ PMID] 10. Xie Y, You Q, Wu C, Cao S, Qu G, Yan X, et al. Impact of cardiovascular disease on clinical characteristics and outcomes of coronavirus disease 2019. Circ J. 2020;84(8):1277-83. [ DOI:10.1253/circj.CJ-20-0348] [ PMID] 11. Frater JL, Zini G, d'Onofrio G, Rogers HJ. COVID-19 and the clinical hematology laboratory. Int J Lab Hematol. 2020;42 Suppl 1:11-8. [ DOI:10.1111/ijlh.13229] [ PMID] [ ] 12. Luo Y, Wang J, Zhang M, Wang Q, Chen R, Wang X, et al. COVID-19-another influential event impacts on laboratory medicine management. J Clin Lab Anal. 2021;35(6):e23804. [ DOI:10.1002/jcla.23804] [ PMID] [ ] |
.png)
.png){kind=small}
